Pfizer-BioNTech say COVID-19 vaccine safe, protective in kids aged 5-11
Pfizer Inc. and BioNTech said on Monday their COVID-19 vaccine induced a robust immune response in five- to 11-year-olds, and they plan to ask for authorization to use the vaccine in children in that age range in the United States, Europe and elsewhere as soon as possible.
‘Waning immunity’ term can lead to false understanding of COVID-19 vaccines, experts say
Some experts say use of the term “waning immunity” to justify whether a third dose of a COVID-19 vaccine booster is needed can give people a false understanding of how the immune system works.
What COVID-19 precautions are being taken on voting day?
As millions of voters head to the polls Monday to vote in the federal election, here are the COVID-19 safety measures Canadians can expect at the polls on voting day.
What COVID-19 precautions to expect at the polls
As millions of voters head to the polls Monday to vote in the federal election, here are the COVID-19 safety measures Canadians can expect at the polls on voting day.
Why vaccine passports may be an important tool in boosting vaccination rates
Provinces across Canada are introducing vaccine passports, allowing those fully vaccinated against COVID-19 to participate in some indoor recreational activities. But apart from that, what do the passports accomplish, and how effective are they? CBC News spoke to some experts.
Goodbye Pfizer, hello Comirnaty: Top COVID-19 vaccines given brand names in Canada
Health Canada has approved brand names for Pfizer, Moderna and Oxford-AstraZeneca vaccines and announced the change on social media today.
COVID-19 during pregnancy means 10 times higher risk of ICU admission, Canadian data suggests
Canadian data suggests people who are pregnant face significantly higher risks of serious COVID-19 requiring hospitalization, ICU admission, or life support — a particular concern because pregnant people tend to have lower rates of vaccination.